Multiple sclerosis associated with antiphospholipid syndrome: Diagnostic and therapeutic difficulties

被引:5
作者
Ahbeddou, N. [1 ]
Ben Haddou, E. Ait [1 ]
Hammi, S. [2 ]
Slimani, C. [1 ]
Regragui, W. [1 ]
Benomar, A. [1 ]
Yahyaoui, M. [1 ]
机构
[1] Hop Specialites, Serv Neurol & Neurogenet B, Rabat, Morocco
[2] Serv Med Interne Hop Mil Instruct Mohamed V, Rabat, Morocco
关键词
Multiple sclerosis; Antiphospholipid syndrome; Antiphospholipid antibodies; ANTICARDIOLIPIN ANTIBODIES; HUGHES-SYNDROME; ANTINUCLEAR; PREVALENCE;
D O I
10.1016/j.neurol.2011.01.021
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Strokes are the main neurological manifestation of antiphospholipid syndrome. Other clinical presentations are possible and may mimic classic symptoms of multiple sclerosis (MS). A 46-year-old woman, with a history of two miscarriages, presented four subacute neurological episodes (optic neuritis, right facial paralysis, paraparesis of the thigh, and right brachial monoparesis). Using McDonald criteria, the diagnosis of multiple sclerosis was retained. Because of the occurrence of thrombocytopenia during a final relapse, we reconsidered the diagnosis of MS. Search for antiphospholipid antibodies was positive. All clinical manifestations and complementary tests were compatible with the diagnosis of antiphospholipid syndrome associated with multiple sclerosis. Given the great similarity of clinical, radiological and biological findings in the two diseases, non-thrombotic neurological manifestations of antiphospholipid syndrome can be difficult to distinguish from MS associated with antiphospholipid syndrome. (C) 2011 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:65 / 69
页数:5
相关论文
共 20 条
[1]  
ALARCONSEGOVIA D, 1989, J RHEUMATOL, V16, P482
[2]   Chorea in the antiphospholipid syndrome - Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature [J].
Cervera, R ;
Asherson, RA ;
Font, J ;
Tikly, M ;
Pallares, L ;
Chamorro, A ;
Ingelmo, M .
MEDICINE, 1997, 76 (03) :203-212
[3]   The interface of multiple sclerosis and antiphospholipid antibodies [J].
Chapman, J .
THROMBOSIS RESEARCH, 2004, 114 (5-6) :477-481
[4]   Frequency and significance of antinuclear antibodies in multiple sclerosis [J].
Collard, RC ;
Koehler, RPM ;
Mattson, DH .
NEUROLOGY, 1997, 49 (03) :857-861
[5]   Multiple sclerosis and antiphospholipid antibodies: study of 62 patients. [J].
Cordoliani, MA ;
Michon-Pasturel, U ;
Rerat, K ;
Arvieux, J ;
Masy, E ;
Hachulla, E ;
Vermersch, P .
REVUE DE MEDECINE INTERNE, 1998, 19 (09) :635-639
[6]   Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature [J].
Cuadrado, MJ ;
Khamashta, MA ;
Ballesteros, A ;
Godfrey, T ;
Simon, MJ ;
Hughes, GRV .
MEDICINE, 2000, 79 (01) :57-68
[7]  
Czlonkowska Anna, 2007, Pol Arch Med Wewn, V117 Suppl, P28
[8]   Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? [J].
Ferreira, S ;
D'Cruz, DP ;
Hughes, GRV .
RHEUMATOLOGY, 2005, 44 (04) :434-442
[9]  
FUKAZAWA T, 1993, ACTA NEUROL SCAND, V88, P184
[10]  
HARADA T, 1995, JPN J OPHTHALMOL, V39, P290